Homburger with ADC Therapeutics on share placement
Homburger advised ADC Therapeutics , a commercial-stage biotechnology company with headquarters in Switzerland, on its USD 60 m private placement of common shares and pre-funded warrants.
TCGX led the operation, with further participation from Redmile Group and other existing investors.
The Homburger team
Daniel Häusermann (corporate / M&A, capital markets, pictured) led the Homburger team on the matter, working alongside Bianca Nedwed (corporate / M&A, capital markets) as well as Stefan Oesterhelt (tax).
